RP
Repare
RPTX·NASDAQMontreal CAFounded 2016180 employees
Small CapbiotechPublicOncology
Platform: Synth Leth
Market Cap
$0.6B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (RPTX)
Loading RPTX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rilutinib | RPT-4076 | Phase 3 | 3 | PD-L1 | SMAHeart Failure | ||
| RPT-8672 | RPT-8672 | Phase 2 | 1 | DLL3 | Psoriasis |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)